Katharina Sophia Volz
Founder and CEO

Katharina Sophia Volz pioneered Stanford University's first Ph.D. in Stem Cell Biology & Regenerative Medicine in 2015, earning her degree in just 2.5 years. She was listed on Forbes 30u30 (Science) and has been immersed in the field of biomedical sciences for the past 12 years, starting with her attendance at Germany's Biotechnology High school. She has been awarded multiple fellowships and awards to do research in 10 labs around the world including Harvard, UCLA, HHMI, Ohio State, TU Graz and Stanford. During her Ph.D. she had a breakthrough discovering the epicardial-derived cell type that forms the coronary arteries and the signal required for this differentiation event. Dr. Volz founded OccamzRazor, an AI-driven neuroscience company OccamzRazor that is focused on creating disease-modifying treatments for Parkinson's Disease (PD) and other complex diseases.